Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma

29 Nov 2023

Abstract excerpt

Clonal hematopoiesis (CH) at time of autologous stem cell transplant (ASCT) has been shown to be associated with decreased overall survival (OS) and progression-free survival (PFS) in patients with multiple myeloma not receiving immunomodulatory drugs (IMiD). However, the significance of CH in newly diagnosed patients, including transplant ineligible patients, and its effect on clonal evolution during multiple...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Cancer Treatment and Pharmacology
Share to Multiple Myeloma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38019104
DOI: 10.1158/2767-9764.crc-23-0093

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple MyelomaPMID 38019104Read ↗

Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis.Semantic proximity Read ↗

Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.Semantic proximity Read ↗

Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.Semantic proximity Read ↗

Clonal Hematopoiesis Impacts Frailty of Newly Diagnosed Multiple Myeloma Patients: A Retrospective Multicentric AnalysisSemantic proximity Read ↗

Multiple Myeloma Insights from Single-Cell Analysis: Clonal Evolution, the Microenvironment, Therapy Evasion, and Clinical ImplicationsSemantic proximity Read ↗

Multiple Myeloma Insights from Single-Cell Analysis: Clonal Evolution, the Microenvironment, Therapy Evasion, and Clinical ImplicationsSemantic proximity Read ↗

Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple MyelomaSemantic proximity Read ↗

Clonal Evolution in Multiple Myeloma.Semantic proximity Read ↗

Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myelomaSemantic proximity Read ↗

A systematic literature review on clonal evolution events preceding relapse in multiple myeloma.Semantic proximity Read ↗

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stabilitySemantic proximity Read ↗

Hunting down the dominating subclone of cancer stem cells as a potential new therapeutic target in multiple myeloma: An artificial intelligence perspectiveSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.